Association of CRP genetic variation and CRP level with elevated PTSD symptoms and physiological responses in a civilian population with high levels of trauma

American Journal of Psychiatry

Volumn 172, Issue 4, 2015, Pages 353-362

  Michopoulos, Vasiliki ^a   Rothbaum, Alex O ^a   Jovanovic, Tanja ^a   Almli, Lynn M ^a   Bradley, Bekh ^a   Rothbaum, Barbara O ^a   Gillespie, Charles F ^a   Ressler, Kerry J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CRP GENE; EMPLOYMENT STATUS; FEAR; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HIGH RISK POPULATION; HUMAN; HYPEREKPLEXIA; MALE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSYCHOTRAUMA; RISK ASSESSMENT; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SOCIAL STATUS; SYMPTOM; URBAN POPULATION; VULNERABLE POPULATION; ASIAN AMERICAN; CAUCASIAN; GENETICS; GENOTYPE; HISPANIC; METABOLISM; MIDDLE AGED; PSYCHOLOGY; STARTLE REFLEX; STATISTICAL MODEL;

ADULT; AFRICAN AMERICANS; ASIAN AMERICANS; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEAR; FEMALE; GENOTYPE; HISPANIC AMERICANS; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REFLEX, STARTLE; STRESS DISORDERS, POST-TRAUMATIC;

EID: 84961290737     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2014.14020263     Document Type: Article

References (60)

1. Boscarino JA: Diseases among men 20 years after exposure to severe stress: implications for clinical research and medical care. Psychosom Med 1997; 59:605-614
2. Boscarino JA: Posttraumatic stress disorder and physical illness: results from clinical and epidemiologic studies. Ann N Y Acad Sci 2004; 1032:141-153
3. Boscarino JA, Chang J: Electrocardiogram abnormalities among men with stress-related psychiatric disorders: implications for coronary heart disease and clinical research. Ann Behav Med 1999; 21:227-234
4. Weiss T, Skelton K, Phifer J, et al: Posttraumatic stress disorder is a risk factor for metabolic syndrome in an impoverished urban population. Gen Hosp Psychiatry 2011; 33:135-142
5. Maes M, Lin AH, Delmeire L, et al: Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events. Biol Psychiatry 1999; 45:833-839
6. Spivak B, Shohat B, Mester R, et al: Elevated levels of serum interleukin-1 beta in combat-related posttraumatic stress disorder. Biol Psychiatry 1997; 42:345-348
7. Smith AK, Conneely KN, Kilaru V, et al: Differential immune system DNA methylation and cytokine regulation in post-traumatic stress disorder. Am J Med Genet B Neuropsychiatr Genet 2011; 156B: 700-708
8. O'Donovan A, Sun B, Cole S, et al: Transcriptional control of monocyte gene expression in post-traumatic stress disorder. Dis Markers 2011; 30:123-132
9. Pace TW, Wingenfeld K, Schmidt I, et al: Increased peripheral NF-kB pathway activity in women with childhood abuse-related posttraumatic stress disorder. Brain Behav Immun 2012; 26:13-17
10. Yehuda R, Golier JA, Yang RK, et al: Enhanced sensitivity to glucocorticoids in peripheral mononuclear leukocytes in posttraumatic stress disorder. Biol Psychiatry 2004; 55:1110-1116
11. von Känel R, Hepp U, Kraemer B, et al: Evidence for low-grade systemic proinflammatory activity in patients with posttraumatic stress disorder. J Psychiatr Res 2007; 41:744-752
12. Raison CL, Capuron L, Miller AH: Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006; 27:24-31
13. Spitzer C, Barnow S, Völzke H, et al: Association of posttraumatic stress disorder with low-grade elevation of C-reactive protein: evidence from the general population. J Psychiatr Res 2010; 44:15-21
14. Miller RJ, Sutherland AG, Hutchison JD, et al: C-reactive protein and interleukin 6 receptor in post-traumatic stress disorder: a pilot study. Cytokine 2001; 13:253-255
15. Söndergaard HP, Hansson LO, Theorell T: The inflammatory markers C-reactive protein and serum amyloid A in refugees with and without posttraumatic stress disorder. Clinica Chim Acta 2004; 342:93-98
16. McCanlies EC, Araia SK, Joseph PN, et al: C-reactive protein, interleukin-6, and posttraumatic stress disorder symptomology in urban police officers. Cytokine 2011; 55:74-78
17. Eraly SA, Nievergelt CM, Maihofer AX, et al; ; Marine Resiliency Study Team: Assessment of plasma C-reactive protein as a biomarker of posttraumatic stress disorder risk. JAMA Psychiatry 2014; 71:423-431
18. Pankow JS, Folsom AR, Cushman M, et al: Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study. Atherosclerosis 2001; 154:681-689
19. Kathiresan S, Larson MG, Vasan RS, et al: Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level. Circulation 2006; 113:1415-1423
20. Lange LA, Carlson CS, Hindorff LA, et al: Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. JAMA 2006; 296:2703-2711
21. Gillespie CF, Bradley B, Mercer K, et al: Trauma exposure and stress-related disorders in inner city primary care patients. Gen Hosp Psychiatry 2009; 31:505-514
22. Jovanovic T, Norrholm SD, Blanding NQ, et al: Impaired fear inhibition is a biomarker of PTSD but not depression. Depress Anxiety 2010; 27:244-251
23. Foa EB, Riggs DS, Dancu CV, et al: Reliability and validity of a brief instrument for assessing post-traumatic stress disorder. J Trauma Stress 1993; 6:459-473
24. Blake DD, Weathers FW, Nagy LM, et al: The development of a Clinician-Administered PTSD Scale. J Trauma Stress 1995; 8:75-90
25. Almeida OP, Norman PE, Allcock R, et al: Polymorphisms of the CRP gene inhibit inflammatory response and increase susceptibility to depression: the Health in Men Study. Int J Epidemiol 2009; 38:1049-1059
26. Kong H, Qian YS, Tang XF, et al: C-reactive protein (CRP) gene polymorphisms, CRP levels, and risk of incident essential hypertension: findings from an observational cohort of Han Chinese. Hypertens Res 2012; 35:1019-1023
27. Hung AM, Crawford DC, Griffin MR, et al: CRP polymorphisms and progression of chronic kidney disease in African Americans. Clin J Am Soc Nephrol 2010; 5:24-33
28. Kettunen T, Eklund C, Kähönen M, et al: Polymorphism in the Creactive protein (CRP) gene affects CRP levels in plasma and one early marker of atherosclerosis in men: the Health 2000 Survey. Scand J Clin Lab Invest 2011; 71:353-361
29. Purcell S, Neale B, Todd-Brown K, et al: PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81:559-575
30. Price AL, Patterson NJ, Plenge RM, et al: Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006; 38:904-909
31. Lin S, Zhoa H: Handbook on Analyzing Human Genetic Data: Computational Approaches and Software. New York, Springer, 2009
32. Delongui F, Kallaur AP, Oliveira SR, et al: Serum levels of high sensitive C reactive protein in healthy adults from southern Brazil. J Clin Lab Anal 2013; 27:207-210
33. Heath NM, Chesney SA, Gerhart JI, et al: Interpersonal violence, PTSD, and inflammation: potential psychogenic pathways to higher C-reactive protein levels. Cytokine 2013; 63:172-178
34. Pace TW, Hu F, Miller AH: Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav Immun 2007; 21:9-19
35. Jovanovic T, Kazama A, Bachevalier J, et al: Impaired safety signal learning may be a biomarker of PTSD. Neuropharmacology 2012; 62:695-704
36. Jovanovic T, Norrholm SD, Fennell JE, et al: Posttraumatic stress disorder may be associated with impaired fear inhibition: relation to symptom severity. Psychiatry Res 2009; 167:151-160
37. Schmitz A, Grillon C, Avenevoli S, et al: Developmental investigation of fear-potentiated startle across puberty. Biol Psychol 2014; 97:15-21
38. Armbruster D, Strobel A, Kirschbaum C, et al: The impact of sex and menstrual cycle on the acoustic startle response. Behav Brain Res 2014; 274:326-333
39. Breslau N: Gender differences in trauma and posttraumatic stress disorder. J Gend Specif Med 2002; 5:34-40
40. Kilpatrick DG, Resnick HS, Milanak ME, et al: National estimates of exposure to traumatic events and PTSD prevalence using DSMIV and DSM-5 criteria. J Trauma Stress 2013; 26:537-547
41. Furman D, Hejblum BP, Simon N, et al: Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination. Proc Natl Acad Sci USA 2014; 111:869-874
42. Klein SL: The effects of hormones on sex differences in infection: from genes to behavior. Neurosci Biobehav Rev 2000; 24:627-638
43. Melamed S, Shirom A, Toker S, et al: Association of fear of terror with low-grade inflammation among apparently healthy employed adults. Psychosom Med 2004; 66:484-491
44. O'Donovan A, SlavichGM, Epel ES, et al: Exaggerated neurobiological sensitivity to threat as a mechanism linking anxiety with increased risk for diseases of aging. Neurosci Biobehav Rev 2013; 37:96-108
45. Lee CC, You NC, Song Y, et al: Relation of genetic variation in the gene coding for C-reactive protein with its plasma protein concentrations: findings from the Women's Health Initiative Observational Cohort. Clin Chem 2009; 55:351-360
46. Spann SJ, Gillespie CF, Davis JS, et al: The association between childhood trauma and lipid levels in an adult low-income, minority population. Gen Hosp Psychiatry 2014; 36:150-155
47. Bradley RG, Binder EB, Epstein MP, et al: Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene. Arch Gen Psychiatry 2008; 65:190-200
48. Binder EB, Bradley RG, Liu W, et al: Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 2008; 299:1291-1305
49. Hammack SE, Cheung J, Rhodes KM, et al: Chronic stress increases pituitary adenylate cyclase-activating peptide (PACAP) and brainderived neurotrophic factor (BDNF) mRNA expression in the bed nucleus of the stria terminalis (BNST): roles for PACAP in anxietylike behavior. Psychoneuroendocrinology 2009; 34:833-843
50. Hashimoto H, Shintani N, Baba A: New insights into the central PACAPergic system from the phenotypes in PACAP-and PACAP receptor-knockout mice. Ann N Y Acad Sci 2006; 1070:75-89
51. Ghzili H, Grumolato L, Thouënnon E, et al: Role of PACAP in the physiology and pathology of the sympathoadrenal system. Front Neuroendocrinol 2008; 29:128-141
52. Ressler KJ, Mercer KB, Bradley B, et al: Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor. Nature 2011; 470:492-497
53. Gillespie CF, Almli LM, Smith AK, et al: Sex dependent influence of a functional polymorphism in steroid 5-a-reductase type 2 (SRD5A2) on post-traumatic stress symptoms. Am J Med Genet B Neuropsychiatr Genet 2013; 162B:283-292
54. Kessler RC, Sonnega A, Bromet E, et al: Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1995; 52:1048-1060
55. Sanip Z, Ariffin FD, Al-Tahami BA, et al: Obesity indices and metabolic markers are related to hs-CRP and adiponectin levels in overweight and obese females. Obes Res Clin Pract 2013; 7:e315-e320
56. Boscarino JA, Kirchner HL, Hoffman SN, et al: Predicting PTSD using the New York Risk Score with genotype data: potential clinical and research opportunities. Neuropsychiatr Dis Treat 2013; 9:517-527
57. Wang L, Cao C, Wang R, et al: PAC1 receptor (ADCYAP1R1) genotype is associated with PTSD's emotional numbing symptoms in Chinese earthquake survivors. J Affect Disord 2013; 150:156-159
58. McDade TW, Hawkley LC, Cacioppo JT: Psychosocial and behavioral predictors of inflammation in middle-aged and older adults: the Chicago health, aging, and social relations study. Psychosom Med 2006; 68:376-381
59. Owen N, Poulton T, Hay FC, et al: Socioeconomic status, Creactive protein, immune factors, and responses to acute mental stress. Brain Behav Immun 2003; 17:286-295
60. Raison CL, Rutherford RE, Woolwine BJ, et al: A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry 2013; 70:31-41